Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T13:45:20.932Z.
Calculation as of: 2026-10-06T13:45:20.932Z.
Quote observation: 2026-10-06T13:43:53.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: bd475241593d5c58f7737f650220a879a7f67ee05652ed27eb0102460b642cb0
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
Acrivon Therapeutics, Inc. Common Stock
Market Cap
$87.10M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$84.44M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$83.97M
EV/EBITDA Ratio
N/A
TTM Avg
8.06x
3Y Avg
8.06x
5Y Avg
8.06x
Market Cap
$89.11M
EV/EBITDA Ratio
14.83x
TTM Avg
15.77x
3Y Avg
20.95x
5Y Avg
32.73x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Acrivon Therapeutics, Inc. Common Stock (ACRV) | $87.10M | N/A | N/A | N/A | N/A |
| Citius Oncology, Inc. (CTOR)vs › | $85.53M | N/A | N/A | N/A | N/A |
| Humacyte, Inc. (HUMA)vs › | $84.52M | N/A | N/A | N/A | N/A |
| Cognition Therapeutics, Inc. (CGTX)vs › | $84.44M | N/A | N/A | N/A | N/A |
| CareCloud, Inc. (CCLD)vs › | $87.11M | 4.64x | 4.46x | 3.36x | 3.41x |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $83.97M | N/A | 8.06x | 8.06x | 8.06x |
| Cardiff Oncology, Inc. (CRDF)vs › | $88.63M | N/A | N/A | N/A | N/A |
| Conexeu Sciences Inc. (CNXU)vs › | $88.84M | N/A | N/A | N/A | N/A |
| ImmuCell Corporation (ICCC)vs › | $89.11M | 14.83x | 15.77x | 20.95x | 32.73x |
| LENSAR Inc (LNSR)vs › | $81.80M | N/A | N/A | N/A | N/A |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
